Form D · Biotechnology
eXIthera Pharmaceuticals, Inc.
Westborough, MA · CIK 0001554842
Offering snapshot reported Aug 25, 2017 · SEC filing
- Reported sold
- $3M Offering amount: $5.4M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 10, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 25, 2017 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
| May 16, 2016 | Amendment | $10,000,000 | $4,000,000vs Aug 15, 2014 | 2 | SEC filing |
| Aug 15, 2014 | Initial | $6,000,000 | No comparison | 2 | SEC filing |
| Aug 13, 2012 | Amendment | $2,000,000 | $0vs Jul 31, 2012 | 1 | SEC filing |
| Jul 31, 2012 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-293500
The total offering amount includes the total amount of interest on the Secured Convertible Promissory Notes.
Secured Convertible Promissory Notes which may be converted into Series B Preferred Stock or other equity securities.
Source: Form D, filed Aug 25, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Behr | Director |
| Ben Bronstein | Director |
| Dennis Goldberg | Director |
| Neil J. Hayward | Director, Executive |
| Isaac Kohlberg | Director |
| William Koster | Director |
| Fred Meyer | Director |
| Frans Stassen | Director |
| Scott Yaphe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1900 West Park Drive Suite 280
Westborough, MA, 01581
Westborough, MA, 01581